Navigation Links
Stage II and stage III colon cancer patients treated after 1995 have improved overall survival
Date:6/3/2010

CHICAGO Patients with stage III colon cancer treated with 5-FU-based chemotherapy after complete surgical removal of their tumor after 1995 had improved overall survival with no change in time to recurrence compared to patients treated before 1995. In contrast, patients with stage II colon cancer treated after 1995 had longer time to recurrence and time from recurrence to death compared to those patients treated prior to 1995, according to Mayo Clinic and Gr Hospitalier Pitie-Salpetriere, Paris, researchers. They will present the study's findings on June 4-8, 2010, at the American Society of Clinical Oncology (http://www.asco.org/) annual meeting in Chicago.

"By combining information from 21 cancer treatment trials for patients with stage II and stage III colon cancer, our analysis determined that those patients treated after 1995 had improved overall survival," says Dan Sargent, Ph.D., Mayo Clinic biostatistician, North Central Cancer Treatment Group (http://ncctg.mayo.edu/) (NCCTG) statistician and senior author on the study.

The analysis compared patient data from more than 18,000 patients with stage II and stage III colon cancer treated with 5-FU-based chemotherapy after their primary tumor had been surgically removed for the time period 1978-1995 versus 1996-2007.

"Patients with stage II colon cancer treated after 1995 had had longer time to recurrence, possibly due to improvements in surgery and pathology" says Dr. Sargent. "In addition, after 1995, both stage II and stage III colon cancer patients treated after surgery with the same 5-FU-based chemotherapy after surgery had improved overall survival. This finding provides evidence to support previous findings that access to new medical therapies introduced in the mid-1990s as well as the expanded use of surgery for patients recurrent disease have meaningfully improving overall survival for patients treated in this setting."

The findings arise from analysis of combined data collected within an expanded database by the Adjuvant Colon Cancer End Points (ACCENT) Group, a consortium of scientists. The ACCENT database includes data from more than 33,500 patients from the United States, Canada, Australia and Europe. ACCENT, chaired by Dr. Sargent, is supported by the NCCTG.


'/>"/>

Contact: Karl Oestreich
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. THE COMPLETE PACKAGE NEW REALITY SHOW SETS STAGE AND NEW STANDARD
2. Translational Regenerative Medicine Forum sets stage for accelerating therapies to patients
3. Immune memory formation seen in early stages of viral infection
4. New Test Might Smell Early Stage Lung Cancer
5. Ultrasound plus proteomic blood analyses may help physicians diagnose early-stage ovarian cancer
6. Study finds racial disparities exist in radiation therapy rates for early stage breast cancer
7. Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer
8. Forests take center stage at Copenhagen
9. Diabetics Less Prone Now to End-Stage Kidney Disease
10. Too Many With End-Stage Dementia Get Feeding Tubes
11. MDS Announces Agreements to Divest MDS Pharma Services Early Stage Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... ... the Pennsylvania Cable Network (PCN) during the summer of 2016. The program was ... provided by the United States Department of Health and Human Services Administration. ...
(Date:12/8/2016)... ... December 08, 2016 , ... After enjoying record-breaking attendance ... today for its 33rd Annual Issues & Research Conference, March 2-3, 2017, ... of the conference is “Persistent Challenges and New Opportunities: Using Research to Accelerate ...
(Date:12/8/2016)... and JENNERSVILLE, Pa. (PRWEB) , ... December 08, ... ... that Penn Medicine Southern Chester County, a Property owned by an affiliate of ... million, 72,000 square foot Penn Medicine Southern Chester County ambulatory care center (ACC) ...
(Date:12/8/2016)... ... ... With the increasing demand for dental implants, the National Association of Dental Laboratories ( ... patients about the safety issues related to dental restorations. According to the American Academy ... to reach $6.4 billion in 2018 with more than 30 million Americans missing all ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... access for customers and employees that are both engaging and easy to use. ... Smart Technology, the software company revealed today its plans to roll out new ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Texas , Dec. 8, 2016 ... program that brings leading-edge laboratory services and management ... United States , allowing more doctors and ... health care management solutions. Logo - ... Hospital systems, under pressure to contain ...
(Date:12/8/2016)... , Dec. 8, 2016 A Small ... the National Institutes of Health (NIH) to ... University.  The grant will seek to ... head device, which utilizes electromagnetic waves to treat Alzheimer,s ... this novel technology to possibly treat other neurologic disorders ...
(Date:12/8/2016)... , Dec. 8, 2016  Boehringer Ingelheim announced ... Corporate Equality Index (CEI). This is the ninth time ... been designated as a Best Place to Work for ... the CEI is a national benchmarking report on corporate ... gay, bisexual and transgender (LGBT) employees. ...
Breaking Medicine Technology: